Results vary, but many clients see progress within the first month
Short-term CS exposure (48 weeks) induces upregulation of PPP-related gene expression in the lung tissue of A/J mice, enhancing PPP activity
However, like any medical treatment, it carries potential risks and side effects, including: -Injection site reactions (redness, pain, swelling) -Hormonal imbalances if misused -Headaches, dizziness, or nausea -Allergic reactions or sensitivity to the compound -Rare interactions with existing medications or conditions -Peptides should only be used under medical supervision
A 2024 study published in PNAS highlighted that both Long COVID and ME/CFS patients exhibit signs of elevated oxidative stress and aberrations in ROS clearance pathways, underscoring the role of redox imbalance in these conditions
Previous studies have shown that internalization of these receptors following ligand stimulation is more pronounced in IR than IGF1R (14), and this effect is decreased in insulin-resistant obese subjects and obese type 2 diabetic patients (24)